Comparison of the effects on glycaemic control and β‐cell function in newly diagnosed type 2 diabetes patients of treatment with exenatide, insulin or pioglitazone: a multicentre randomized parallel‐group trial (the <scp>CONFIDENCE</scp> study)Wen Xu, Jianping Weng, Lei Qiu et al.|Journal of Internal Medicine|2014Cited by 59
Direct medical costs for patients with type 2 diabetes in 16 tertiary hospitals in urban China: A multicenter prospective cohort studyXiang Li, Jianping Weng, Zhangrong Xu et al.|Journal of Diabetes Investigation|2018Cited by 59
Caveolin-1 Is Essential for the Improvement of Insulin Sensitivity through AKT Activation during Glargine Treatment on Diabetic MiceHangya Peng, Longyi Zeng|Journal of Diabetes Research|2021Cited by 15
Glucokinase activator improves glucose tolerance and induces hepatic lipid accumulation in mice with diet-induced obesityNan Cai, Longyi Zeng|Liver Research|2023Cited by 5